Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 783

1.

Pneumococcal vaccines: understanding centers for disease control and prevention recommendations.

Mirsaeidi M, Schraufnagel DE.

Ann Am Thorac Soc. 2014 Jul;11(6):980-5. doi: 10.1513/AnnalsATS.201401-042CME.

PMID:
25032872
[PubMed - in process]
2.

Review: Current and new generation pneumococcal vaccines.

Feldman C, Anderson R.

J Infect. 2014 Jun 23. pii: S0163-4453(14)00166-2. doi: 10.1016/j.jinf.2014.06.006. [Epub ahead of print] Review.

PMID:
24968238
[PubMed - as supplied by publisher]
3.

Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction.

Scotta MC, Veras TN, Klein PC, Tronco V, Polack FP, Mattiello R, Pitrez PM, Jones MH, Stein RT, Pinto LA.

Vaccine. 2014 Jul 31;32(35):4495-9. doi: 10.1016/j.vaccine.2014.06.042. Epub 2014 Jun 21.

PMID:
24958703
[PubMed - in process]
4.

Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.

Hortal M, Estevan M, Meny M, Iraola I, Laurani H.

PLoS One. 2014 Jun 6;9(6):e98567. doi: 10.1371/journal.pone.0098567. eCollection 2014.

PMID:
24905093
[PubMed - in process]
Free PMC Article
5.

Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.

Tregnaghi MW, Sáez-Llorens X, López P, Abate H, Smith E, Pósleman A, Calvo A, Wong D, Cortes-Barbosa C, Ceballos A, Tregnaghi M, Sierra A, Rodriguez M, Troitiño M, Carabajal C, Falaschi A, Leandro A, Castrejón MM, Lepetic A, Lommel P, Hausdorff WP, Borys D, Ruiz Guiñazú J, Ortega-Barría E, Yarzábal JP, Schuerman L; COMPAS Group.

PLoS Med. 2014 Jun 3;11(6):e1001657. doi: 10.1371/journal.pmed.1001657. eCollection 2014 Jun.

PMID:
24892763
[PubMed - in process]
Free PMC Article
6.

Etiology of Severe Childhood Pneumonia in The Gambia, West Africa, Determined by Conventional and Molecular Microbiological Analyses of Lung and Pleural Aspirate Samples.

Howie SR, Morris GA, Tokarz R, Ebruke BE, Machuka EM, Ideh RC, Chimah O, Secka O, Townend J, Dione M, Oluwalana C, Njie M, Jallow M, Hill PC, Antonio M, Greenwood B, Briese T, Mulholland K, Corrah T, Lipkin WI, Adegbola RA.

Clin Infect Dis. 2014 May 27. pii: ciu384. [Epub ahead of print]

PMID:
24867789
[PubMed - as supplied by publisher]
7.

The contribution of vaccination to global health: past, present and future.

Greenwood B.

Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130433. doi: 10.1098/rstb.2013.0433. Print 2014.

PMID:
24821919
[PubMed - in process]
8.

[A pediatric case of pneumococcal meningitis due to Streptococcus pneumoniae serotype 35F].

Kara SS, Polat M, Tapisiz A, Nar Otgun S, Tezer H.

Mikrobiyol Bul. 2014 Apr;48(2):346-50. Turkish.

PMID:
24819273
[PubMed - in process]
Free Article
9.

Pneumococcal conjugate vaccines for adults: Reasons for optimism and for caution.

Weinberger DM, Shapiro ED.

Hum Vaccin Immunother. 2014 Apr 24;10(5). [Epub ahead of print] No abstract available.

PMID:
24763136
[PubMed - as supplied by publisher]
10.

Engineered PRINT® nanoparticles for controlled delivery of antigens and immunostimulants.

Beletskii A, Galloway A, Rele S, Stone M, Malinoski F.

Hum Vaccin Immunother. 2014 Apr 22;10(7). [Epub ahead of print]

PMID:
24755482
[PubMed - as supplied by publisher]
11.

Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model.

Verhoeven D, Xu Q, Pichichero ME.

Vaccine. 2014 May 30;32(26):3205-10. doi: 10.1016/j.vaccine.2014.04.004. Epub 2014 Apr 13.

PMID:
24731814
[PubMed - in process]
12.

Reduction of Invasive Pneumococcal Disease 3 Years After the Introduction of the 13-Valent Conjugate Vaccine in the Oxfordshire Region of England.

Moore CE, Paul J, Foster D, Mahar SA, Griffiths D, Knox K, Peto TE, Walker AS, Crook DW; for the Oxford Invasive Pneumococcal Surveillance Group.

J Infect Dis. 2014 Apr 9. pii: jiu213. [Epub ahead of print]

PMID:
24719477
[PubMed - as supplied by publisher]
13.

Cost-effectiveness of pneumococcal vaccines for adults in the United States.

Chen J, O'Brien MA, Yang HK, Grabenstein JD, Dasbach EJ.

Adv Ther. 2014 Apr;31(4):392-409. doi: 10.1007/s12325-014-0115-y. Epub 2014 Apr 10.

PMID:
24718851
[PubMed - in process]
Free PMC Article
14.

Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland.

Keitel K, Alcoba G, Lacroix L, Manzano S, Galetto-Lacour A, Gervaix A.

Swiss Med Wkly. 2014 Apr 2;144:w13925. doi: 10.4414/smw.2014.13925. eCollection 2014.

PMID:
24706389
[PubMed - in process]
Free Article
15.

Comparative simulation of pneumococcal serogroup 19 polysaccharide repeating units with two carbohydrate force fields.

Kuttel M, Gordon M, Ravenscroft N.

Carbohydr Res. 2014 May 22;390:20-7. doi: 10.1016/j.carres.2014.02.026. Epub 2014 Mar 11.

PMID:
24681444
[PubMed - in process]
16.

Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia.

Ordóñez JE, Orozco JJ.

BMC Infect Dis. 2014 Mar 28;14:172. doi: 10.1186/1471-2334-14-172.

PMID:
24679135
[PubMed - in process]
Free PMC Article
17.

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines.

Lee H, Choi EH, Lee HJ.

Korean J Pediatr. 2014 Feb;57(2):55-66. doi: 10.3345/kjp.2014.57.2.55. Epub 2014 Feb 24.

PMID:
24678328
[PubMed]
Free PMC Article
18.

A179: improving pneumococcal vaccination rate in the pediatric rheumatology clinic.

Harris JG, Maletta KI, Ren B, Olson JC.

Arthritis Rheumatol. 2014 Mar;66 Suppl 11:S234. doi: 10.1002/art.38605.

PMID:
24677936
[PubMed - in process]
19.

Severe Streptococcus pneumoniae 19A pneumonia with empyema in children vaccinated with pneumococcal conjugate vaccines.

Lu CY, Ting YT, Huang LM.

J Formos Med Assoc. 2014 Mar 24. pii: S0929-6646(14)00070-9. doi: 10.1016/j.jfma.2014.02.007. [Epub ahead of print] No abstract available.

PMID:
24674951
[PubMed - as supplied by publisher]
20.

Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults.

Grabenstein JD, Musey LK.

Vaccine. 2014 May 1;32(21):2399-405. doi: 10.1016/j.vaccine.2014.02.096. Epub 2014 Mar 14.

PMID:
24637174
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk